Tag results
Trials tagged with: "alemtuzumab"
Eradication of Minimal Residual Disease (MRD) in
patients with Chronic Lymphocytic Leukaemia (CLL)
with Alemtuzumab: A Phase II Study
A Phase II Trial to Evaluate the Efficacy and Safety of Subcutaneously Administered Alemtuzumab (CAMPATH®, MabCampath®) in Patients with Previously Treated B-Cell Chronic Lymphocytic Leukemia
A phase I dose escalation study to establish the maximal tolerated dose of Campath in combination with CHOP and to assess the toxicity of the combination in the primary treatment of peripheral T cell lymphoma (PTCL).